(May 24, 2017, 10:44 AM EDT) -- BROOKLYN, N.Y. — Two medical experts lack the qualifications and reliable methodology to opine that a mother’s use of an anti-epileptic drug linked to birth defects caused her son’s severe birth defects, so summary judgment for the drugmaker is warranted on the mother’s failure-to-warn claims, a New York federal magistrate judge held May 22 (N.K., an infant, by his mother and natural guardian, Tanja Bruestle-Kumra v. Abbott Laboratories, No. 14-cv-4875, E.D. N.Y., 2017 U.S. Dist. LEXIS 77461)....